These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 20576233)
21. Intravenous immunoglobulin-associated acute renal failure: case series and literature review. Itkin YM; Trujillo TC Pharmacotherapy; 2005 Jun; 25(6):886-92. PubMed ID: 15927908 [TBL] [Abstract][Full Text] [Related]
22. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis]. Cherin P Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990 [TBL] [Abstract][Full Text] [Related]
23. [Acute renal failure after intravenous use of immunoglobulin to treat myocarditis]. Pordeus V; Tostes A; Mesquita CT; Mady C; Mesquita ET Arq Bras Cardiol; 2005 Feb; 84(2):167-9. PubMed ID: 15761642 [TBL] [Abstract][Full Text] [Related]
24. Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient. Metallidis S; Papaioannou M; Bokolas G; Kollaras P; Gogou V; Nikolaidis P Clin Nephrol; 2009 Feb; 71(2):196-7. PubMed ID: 19203515 [TBL] [Abstract][Full Text] [Related]
25. [Acute kidney injury (AKI) requireing renal replacement therapy in a patient treated with intravenous immunoglobulin]. Wojtecka A; Kade G; Bilbin-Bukowska A; Niemczyk S Pol Merkur Lekarski; 2012 Mar; 32(189):173-5. PubMed ID: 22568183 [TBL] [Abstract][Full Text] [Related]
26. [Acute kidney failure following intravenous administration of high doses of immunoglobulins]. Cabre P; Smadja D; Odry L; Donikian JC; Vernant JC Presse Med; 1994 Jan; 23(3):142. PubMed ID: 8177854 [No Abstract] [Full Text] [Related]
27. Important drug information: immune globulin intravenous (human). Epstein JS; Gaines A; Kapit R; Pierce R; Potter R; Varricchio F Int J Trauma Nurs; 1999; 5(4):139-40. PubMed ID: 10661146 [No Abstract] [Full Text] [Related]
28. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419 [TBL] [Abstract][Full Text] [Related]
29. [Acute renal insufficiency and cerebral infarction during high-dose intravenous immunoglobulin therapy]. Chatot-Henry C; Smadja D; Mehdaoui H; Fournerie P; Drault JN; Brébion A; Sobesky G Rev Med Interne; 1998 Dec; 19(12):914-6. PubMed ID: 9887459 [TBL] [Abstract][Full Text] [Related]
30. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report. Winward DB; Brophy MT Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385 [TBL] [Abstract][Full Text] [Related]
31. [Efficacy of early treatment with intravenous immunoglobulins in severe forms of dermatomyositis]. Escriche D; de la Cruz J; Moreno MJ; Romero J Med Clin (Barc); 1995 Jan; 104(2):79. PubMed ID: 7869785 [No Abstract] [Full Text] [Related]
32. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy. Chacko B; John GT; Balakrishnan N; Kirubakaran MG; Jacob CK Ren Fail; 2006; 28(2):193-5. PubMed ID: 16538981 [TBL] [Abstract][Full Text] [Related]
33. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis]. Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1979-82. PubMed ID: 8413708 [TBL] [Abstract][Full Text] [Related]